News

Pronova BioPharma to be listed in Oslo

Pronova BioPharma ASA, which has a patented method of extracting and concentrating omega-3 ethyl esters from fish oil, is having its shares listed on the Oslo Stock Exchange in an initial public offering (IPO) of 105,915,432 shares at a price of between NOK 23 and NOK 29 per share.

Stem Cell Sciences in new FP6 collaboration

Stem Cell Sciences Plc said it is coordinator of a new collaboration that will design bioassays that can be used to discover new candidates for treating cancer, Alzheimer’s disease, stroke and epilepsy.

MRC supports women who donate eggs for stem-cell research

The UK Medical Research Council (MRC) said that it will fund a research project from the North East England Stem Cell Institute that involves partially financing in vitro fertilisation (IVF) treatments for women who donate their surplus eggs for stem-cell research.

Oxford BioMedica set to receive €9 million milestone payment

Oxford BioMedica Plc said that it has reached the first development milestone in its collaboration with Sanofi-Aventis to produce a cancer immunotherapy product, leading to a payment of €9 million. The product, TroVax, targets the tumour antigen 5T4 which appears in a wide range of solid tumours.